家庭肠内营养在食管癌患者中有效性和安全性的Meta分析

doi:10.12114/j.issn.1007-9572.2022.0853

中国全科医学 ›› 2023, Vol. 26 ›› Issue (20): 2540-2547.DOI: 10.12114/j.issn.1007-9572.2022.0853

所属专题：肿瘤最新文章合辑；消化系统疾病最新文章合辑；营养最新文章合辑

家庭肠内营养在食管癌患者中有效性和安全性的Meta分析

薛珊¹, 李来有¹^,^*(), 梁军利¹, 靳英辉², 魏淑艳³

1．050011　河北省石家庄市，河北医科大学第四医院护理部
2．430071　湖北省武汉市，武汉大学中南医院循证与转化医学中心
3．050011　河北省石家庄市，河北医科大学第四医院麻醉科

收稿日期:2022-10-24 修回日期:2023-01-26 出版日期:2023-07-15 发布日期:2023-03-28
通讯作者: 李来有
作者贡献：薛珊提出方案设计，负责文献/资料整理，撰写论文；梁军利负责数据的分析/解释；靳英辉对文章整体负责，监督管理；魏淑艳进行研究的指导和审校；李来有负责研究的可行性分析、文章质量控制和审校。

The Efficacy and Safety of Home Enteral Nutrition in Patients with Esophageal Cancer: a Meta-analysis

XUE Shan¹, LI Laiyou¹^,^*(), LIANG Junli¹, JIN Yinghui², WEI Shuyan³

1. Department of Nursing, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
2. Center for Evidence-based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
3. Department of Anesthesiology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China

Received:2022-10-24 Revised:2023-01-26 Published:2023-07-15 Online:2023-03-28
Contact: LI Laiyou

摘要/Abstract

摘要： 背景食管癌患者常发生营养不良，国内外研究显示，营养不良严重影响患者的恢复。目前居家期间接受家庭肠内营养（HEN）的患者越来越多，但HEN对食管癌患者的有效性和安全性并不明确。目的通过Meta分析评价HEN对食管癌患者的有效性和安全性。方法计算机检索PubMed、Cochrane Library、Embase、Web of Science、CINAHL、Scopus、万方数据知识服务平台、中国知网、维普网及中国生物医学文献数据库，搜集有关食管癌患者接受HEN的随机对照试验，检索时限从建库至2021年12月。试验组患者接受HEN支持〔肠内管饲（ETF）和口服营养补充（ONS）均可〕，对照组仅接受常规口服饮食。由2名研究者独立筛选文献、提取资料，并采用Cochrane协作网推荐的RoB 2.0工具对文献进行质量评价。采用RevMan 5.4.1软件进行Meta分析。结果共纳入14篇文献，包括1 040例食管癌患者。Meta分析结果显示，试验组患者体质量增长值、BMI增长值、血红蛋白增长值、血清总蛋白增长值、血清前白蛋白增长值、血清转铁蛋白增长值均高于对照组〔SMD=0.63，95%CI（0.40，0.85），P<0.000 01；SMD=0.60，95%CI（0.44，0.76），P<0.000 01；SMD=1.58，95%CI（1.37，1.79），P<0.000 01；SMD=1.19，95%CI（0.79，1.58），P<0.000 01；SMD=0.97，95%CI（0.79，1.14），P<0.000 01；SMD=1.12，95%CI（0.45，1.79），P=0.001〕。在ETF亚组和ONS亚组分析中，试验组血清白蛋白增长值均高于对照组〔SMD=1.25，95%CI（0.82，1.68），P<0.000 01；SMD=0.61，95%CI（0.26，0.97），P<0.000 01〕。试验组营养不良发生率低于对照组〔OR=0.47，95%CI（0.33，0.67），P<0.000 1〕。两组胃肠道并发症发生率比较，差异无统计学意义〔RR=1.33，95%CI（1.00，1.77），P=0.05〕。试验组和对照组生活质量评分比较，差异无统计学意义〔MD=4.97，95%CI（0.06，9.87），P=0.05〕；试验组躯体功能评分高于对照组〔MD=6.67，95%CI（2.86，10.48），P=0.000 6〕，疲劳症状评分低于对照组〔MD=-7.31，95%CI（-11.85，-2.77），P=0.002〕。敏感性分析结果显示，合并结果稳定可靠。结论 HEN能够改善食管癌术后出院患者的营养状况和躯体功能，并减轻患者的疲劳症状，且并未增加胃肠道并发症的发生率，但暂未发现能够改善患者总体生活质量。

关键词: 食管肿瘤, 肠道营养, 家庭肠内营养, 管饲喂养, 口服营养补充, 营养状况, 生活质量, 随机对照试验, Meta分析

Abstract:

Background

Malnutrition is a common complication in patients with esophageal cancer, which has been validated by domestic and international studies to seriously impact the recovery of patients. While the number of patients receiving home enteral nutrition (HEN) is increasing, the effectiveness and safety of HEN for patients with esophageal cancer remains unclear.

Objective

To systematically evaluate the effectiveness and safety of HEN by meta-analysis.

Methods

RCTs on the HEN in patients with esophageal cancer were retrieved in PubMed, Cochrane Library, Embase, Web of Science, CINAHL, Scopus, Wanfang Data, CNKI, VIP and CBM from inception to December 2021. Patients in the experimental group received HEN support〔both enteral tube feeding (ETF) and oral nutritional supplement (ONS) were both acceptable〕, while patients in the control group received conventional oral diet only. Two researchers independently screened the literature and extracted data. The RoB 2.0 recommended by the Cochrane Collaboration was used to evaluate the quality of the included studies, and the RevMan 5.4.1 software was used to perform the meta-analysis.

Results

A total of 14 articles were included, involving 1 040 patients with esophageal cancer. Meta-analysis showed that the increase values of body mass, BMI, hemoglobin, serum total protein, serum prealbumin and serum transferrin in the experimental group were higher than those in the control group〔SMD=0.63, 95%CI (0.40, 0.85), P<0.000 01; SMD=0.60, 95%CI (0.44, 0.76), P<0.000 01; SMD=1.58, 95%CI (1.37, 1.79), P<0.000 01; SMD=1.19, 95%CI (0.79, 1.58), P<0.000 01; SMD=0.97, 95%CI (0.79, 1.14), P<0.000 01; SMD=1.12, 95%CI (0.45, 1.79), P=0.001〕. The increase value of serum albumin in the experimental group was higher than that in the control group in both ETF and ONS subgroups analysis〔SMD=1.25, 95%CI (0.82, 1.68), P<0.000 01; SMD=0.61, 95%CI (0.26, 0.97), P<0.000 01〕. The incidence of malnutrition was lower in the experimental group than in the control group〔OR=0.47, 95%CI (0.33, 0.67), P<0.000 1〕. There was no statistically significant differences in the incidence of gastrointestinal complications〔RR=1.33, 95%CI (1.00, 1.77), P=0.05〕and life quality score〔MD=4.97, 95%CI (0.06, 9.87), P=0.05〕 between the two groups. The physical function score of the experimental group was higher than that of the control group〔MD=6.67, 95%CI (2.86, 10.48), P=0.000 6〕, and the fatigue symptom score was lower than that of the control group〔MD=-7.31, 95%CI (-11.85, -2.77), P=0.002〕. Sensitivity analysis showed that the combined results were stable and reliable.

Conclusion

HEN can significantly improve the nutritional status and physical function, reduce fatigue symptoms of discharged patients after esophageal cancer surgery, and does not increase the incidence of gastrointestinal complications, however, it has not been found to improve the global overall quality of life.

Key words: Esophageal neoplasms, Enteral nutrition, Home enteral nutrition, Enteral tube feeding, Oral nutritional supplements, Nutritional status, Quality of life, Randomized controlled trial, Meta-analysis

薛珊,李来有,梁军利,等. 家庭肠内营养在食管癌患者中有效性和安全性的Meta分析[J]. 中国全科医学, 2023, 26(20): 2540-2547. DOI: 10.12114/j.issn.1007-9572.2022.0853.
XUE Shan,LI Laiyou,LIANG Junli, et al. The Efficacy and Safety of Home Enteral Nutrition in Patients with Esophageal Cancer: a Meta-analysis[J]. Chinese General Practice, 2023, 26(20): 2540-2547. DOI: 10.12114/j.issn.1007-9572.2022.0853.

图/表 16

参考文献 41

[1]	曹毛毛，陈万青. 中国恶性肿瘤流行情况及防控现状[J]. 中国肿瘤临床，2019，46(3):145-149. DOI：10.3969/j.issn.1000-8179.2019.03.246.
[2]	SONG C H, CAO J J, ZHANG F，et al. Nutritional risk assessment by scored patient-generated subjective global assessment associated with demographic characteristics in 23，904 common malignant tumors patients[J]. Nutr Cancer，2019，71(1):50-60. DOI：10.1080/01635581.2019.1566478.
[3]	温静. 食管癌患者营养状况与治疗相关性的研究进展[J]. 肿瘤预防与治疗，2017，30(3):213-218. DOI：10.3969/j.issn.1674-0904.2017.03.012.
[4]	CHEN M J, WU I C, CHEN Y J，et al. Nutrition therapy in esophageal cancer-consensus statement of the Gastroenterological Society of Taiwan [J]. Dis Esophagus，2018，31(8). DOI：10.1093/dote/doy016.
[5]	陈静儒，张振香，郭瑾，等. 照顾者对食管癌患者营养照护的质性研究[J]. 中国实用护理杂志，2018，34(2):126-130. DOI：10.3760/cma.j.issn.1672-7088.2018.02.011.
[6]	MATSUOKA M, IIJIMA S. Consideration of nutritional support for decreased caloric intake in patients with severe weight loss after esophageal cancer surgery[J]. Gan To Kagaku Ryoho，2019，46(Suppl 1):132-134.
[7]	HAVERKORT E B, BINNEKADE J M, DE HAAN R J，et al. Suboptimal intake of nutrients after esophagectomy with gastric tube reconstruction[J]. J Acad Nutr Diet，2012，112(7):1080-1087. DOI：10.1016/j.jand.2012.03.032.
[8]	MARIETTE C, DE BOTTON M L, PIESSEN G. Surgery in esophageal and gastric cancer patients：what is the role for nutrition support in your daily practice?[J]. Ann Surg Oncol，2012，19(7):2128-2134. DOI：10.1245/s10434-012-2225-6.
[9]	医学名词审定委员会.肠外肠内营养学名词[M].北京：科学出版社，2019：11.
[10]	BISCHOFF S C, AUSTIN P, BOEYKENS K，et al. ESPEN guideline on home enteral nutrition[J]. Clin Nutr，2020，39(1):5-22. DOI：10.1016/j.clnu.2019.04.022.
[11]	LIU K, JI S, XU Y，et al. Safety，feasibility，and effect of an enhanced nutritional support pathway including extended preoperative and home enteral nutrition in patients undergoing enhanced recovery after esophagectomy：a pilot randomized clinical trial[J]. Dis Esophagus，2020，33(2):doz030. DOI：10.1093/dote/doz030.
[12]	ZENG J, HU J, CHEN Q X，et al. Home enteral nutrition's effects on nutritional status and quality of life after esophagectomy[J]. Asia Pac J Clin Nutr，2017，26(5):804-810. DOI：10.6133/apjcn.112016.07.
[13]	DONOHOE C L, HEALY L A, FANNING M，et al. Impact of supplemental home enteral feeding postesophagectomy on nutrition，body composition，quality of life，and patient satisfaction[J]. Dis Esophagus，2017，30(9):1-9. DOI：10.1093/dote/dox063.
[14]	WEIMANN A, BRAGA M, CARLI F，et al. ESPEN guideline：clinical nutrition in surgery[J]. Clin Nutr，2017，36(3):623-650. DOI：10.1016/j.clnu.2017.02.013.
[15]	HIGGINS J，THOMAS J，CHANDLER J，et al. Cochrane handbook for systematic reviews of interventions Version 6.0[Z]. 2019.
[16]	HIGGINS J P, GREEN S. Cochrane handbook for systematic reviews of interventions，Version 5.1.0[M]. New York：The Cochrane Collaboration，2011.
[17]	BOWREY D J, BAKER M, HALLIDAY V，et al. A randomised controlled trial of six weeks of home enteral nutrition versus standard care after oesophagectomy or total gastrectomy for cancer：report on a pilot and feasibility study[J]. Trials，2015，16:531. DOI：10.1186/s13063-015-1053-y.
[18]	XIE H N, CHEN X K, XU L，et al. A randomized controlled trial of oral nutritional supplementation versus standard diet following McKeown minimally invasive esophagectomy in patients with esophageal malignancy：a pilot study[J]. Ann Transl Med，2021，9(22):1674. DOI：10.21037/atm-21-5422.
[19]	CHEN T T, JIANG W, HE G M. Effect of family enteral nutrition on nutritional status in elderly patients with esophageal carcinoma after minimally invasive radical surgery：a randomized trial[J]. Ann Palliat Med，2021，10(6):6760-6767. DOI：10.21037/apm-21-1219.
[20]	LI X K, CONG Z Z, WU W J，et al. Efficacy of 4 wk of home enteral feeding supplementation after esophagectomy on immune function：a randomized controlled trial[J]. Nutrition，2020，77:110787. DOI：10.1016/j.nut.2020.110787.
[21]	CHEN X Y, ZHAO G Y, ZHU L G. Home enteral nutrition for postoperative elderly patients with esophageal cancer[J]. Ann Palliat Med，2021，10(1):278-284. DOI：10.21037/apm-20-2197.
[22]	ZENG J, HU J, CHEN Q X，et al. Home enteral nutrition's effects on nutritional status and quality of life after esophagectomy[J]. Asia Pac J Clin Nutr，2017，26(5):804-810. DOI：10.6133/apjcn.112016.07.
[23]	范富翠，童雅萍，梁冠冕，等. NRS2002结合营养指标评价食管癌术后出院患者的营养状况[J]. 广东医学，2020，41(19):1970-1974. DOI：10.13820/j.cnki.gdyx.20200938.
[24]	曹子昂，潘文标，梁而慷，等. 穿刺导管空肠造口术对食管癌患者术后肠内营养支持的临床意义[J]. 中华临床医师杂志：电子版，2013，7(14):6355-6357. DOI：10.3877/cma.j.issn.1674-0785.2013.14.033.
[25]	童雅萍，谢玲女，沈祝苹，等. 家庭肠内营养对食管癌根治术后患者营养状况的影响研究[J]. 护士进修杂志，2018，33(6):493-496. DOI：10.16821/j.cnki.hsjx.2018.06.005.
[26]	刘秀娟. 家庭肠内营养对微创食管癌根治术后患者营养状况的影响[J]. 中国临床护理，2021，13(3):158-161,164. DOI：10.3969/j.issn.1674-3768.2021.03.006.
[27]	王倩，王振华，王萍，等. 家庭肠内营养支持治疗对食管癌切除术后患者营养状况的影响[J]. 医学临床研究，2019，36(8):1651-1652. DOI：10.3969/j.issn.1671-7171.2019.08.077.
[28]	谷金玲，龚太乾，宋伟安，等. 家庭肠内营养治疗对微创食管癌根治术后营养状况的影响[J]. 武警医学，2020，31(8):657-660. DOI：10.14010/j.cnki.wjyx.2020.08.004.
[29]	石海燕，陈宏林，吴超，等. 口服营养补充对食管癌根治术后出院患者营养状况影响的研究[J]. 中国现代医生，2021，59(11):176-179.
[30]	HYNES O, ANANDAVADIVELAN P, GOSSAGE J，et al. The impact of pre- and post-operative weight loss and body mass index on prognosis in patients with oesophageal cancer[J]. Eur J Surg Oncol，2017，43(8):1559-1565. DOI：10.1016/j.ejso.2017.05.023.
[31]	MATSUOKA M, IIJIMA S. Consideration of nutritional support for decreased caloric intake in patients with severe weight loss after esophageal cancer surgery[J]. Gan To Kagaku Ryoho，2019，46(Suppl 1):132-134.
[32]	BAKER M L, HALLIDAY V, ROBINSON P，et al. Nutrient intake and contribution of home enteral nutrition to meeting nutritional requirements after oesophagectomy and total gastrectomy[J]. Eur J Clin Nutr，2017，71(9):1121-1128. DOI：10.1038/ejcn.2017.88.
[33]	HAVERKORT E B, BINNEKADE J M, DE HAAN R J，et al. Suboptimal intake of nutrients after esophagectomy with gastric tube reconstruction[J]. J Acad Nutr Diet，2012，112(7):1080-1087. DOI：10.1016/j.jand.2012.03.032.
[34]	KINGMA B F, STEENHAGEN E, RUURDA J P，et al. Nutritional aspects of enhanced recovery after esophagectomy with gastric conduit reconstruction[J]. J Surg Oncol，2017，116(5):623-629. DOI：10.1002/jso.24827.
[35]	MCKERNAN M, MCMILLAN D C, ANDERSON J R，et al. The relationship between quality of life （EORTC QLQ-C30） and survival in patients with gastro-oesophageal cancer[J]. Br J Cancer，2008，98(5):888-893. DOI：10.1038/sj.bjc.6604248.
[36]	SYN N L, WEE I, SHABBIR A，et al. Pouch versus No pouch following total gastrectomy：meta-analysis of randomized and non-randomized studies[J]. Ann Surg，2019，269(6):1041-1053. DOI：10.1097/SLA.0000000000003082.
[37]	GANNON J A, GUINAN E M, DOYLE S L，et al. Reduced fitness and physical functioning are long-term sequelae after curative treatment for esophageal cancer：a matched control study[J]. Dis Esophagus，2017，30(8):1-7. DOI：10.1093/dote/dox018.
[38]	ELLIOTT J A, DOYLE S L, MURPHY C F，et al. Sarcopenia：prevalence，and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer[J]. Ann Surg，2017，266(5):822-830. DOI：10.1097/SLA.0000000000002398.
[39]	郭敏，殷秀敏，王翠，等. 食管癌患者术后3个月症状群的调查[J]. 中华护理杂志，2019，54(8):1189-1193. DOI：10.3761/j.issn.0254-1769.2019.08.014.
[40]	SMALLEY S R, BENEDETTI J K, HALLER D G，et al. Updated analysis of SWOG-directed intergroup study 0116：a phase Ⅲ trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection[J]. J Clin Oncol，2012，30(19):2327-2333. DOI：10.1200/JCO.2011.36.7136.
[41]	HEALY L A, RYAN A M, MOORE J，et al. Health-related quality of life assessment at presentation may predict complications and early relapse in patients with localized cancer of the esophagus[J]. Dis Esophagus，2008，21(6):522-528. DOI：10.1111/j.1442-2050.2008.00814.x.

步骤	检索式
#1	"Esophageal Neoplasms" [MeSH] OR "esophageal neoplasm" [Title] OR "esophageal neoplasms" [Title] OR "cancer of esophagus" [Title] OR "cancer of the esophagus" [Title] OR "esophagus cancer" [Title] OR "esophagus cancers" [Title] OR "esophageal cancer" [Title] OR "esophageal cancers" [Title] OR "esophageal carcinoma" [Title] OR "esophagus carcinoma" [Title] OR "esophagectomy" [Title] OR "esophagus resection" [Title] OR "postesophagectomy" [Title]
#2	"Enteral Nutrition" [MeSH] OR "home enteral nutrition" [Title/Abstract] OR "family enteral nutrition" [Title/Abstract] OR "enteral nutrition" [Title/Abstract] OR "enteral nutritional" [Title/Abstract] OR "nasogastric gavage" [Title/Abstract] OR "tube feeding" [Title/Abstract] OR "enteral feeding" [Title/Abstract] OR "enteric feeding" [Title/Abstract] OR "jejunostomy" [Title/Abstract] OR "oral nutritional supplements" [Title/Abstract] OR "ONS" [Title/Abstract]
#3	#1 AND #2
#4	"aftercare" [All Fields] OR "discharge" [All Fields] OR "home" [All Fields] OR "family" [All Fields] OR "community" [All Fields]
#5	#3 AND #4

步骤	检索式
#1	"Esophageal Neoplasms" [MeSH] OR "esophageal neoplasm" [Title] OR "esophageal neoplasms" [Title] OR "cancer of esophagus" [Title] OR "cancer of the esophagus" [Title] OR "esophagus cancer" [Title] OR "esophagus cancers" [Title] OR "esophageal cancer" [Title] OR "esophageal cancers" [Title] OR "esophageal carcinoma" [Title] OR "esophagus carcinoma" [Title] OR "esophagectomy" [Title] OR "esophagus resection" [Title] OR "postesophagectomy" [Title]
#2	"Enteral Nutrition" [MeSH] OR "home enteral nutrition" [Title/Abstract] OR "family enteral nutrition" [Title/Abstract] OR "enteral nutrition" [Title/Abstract] OR "enteral nutritional" [Title/Abstract] OR "nasogastric gavage" [Title/Abstract] OR "tube feeding" [Title/Abstract] OR "enteral feeding" [Title/Abstract] OR "enteric feeding" [Title/Abstract] OR "jejunostomy" [Title/Abstract] OR "oral nutritional supplements" [Title/Abstract] OR "ONS" [Title/Abstract]
#3	#1 AND #2
#4	"aftercare" [All Fields] OR "discharge" [All Fields] OR "home" [All Fields] OR "family" [All Fields] OR "community" [All Fields]
#5	#3 AND #4

第一作者	发表时间（年）	样本量（E/C）	年龄（E/C）	病理分期（Ⅰ/Ⅱ /Ⅲ/Ⅳ）	干预措施及持续时间（E/C）	结局指标
LIU^[11]	2020	26/24	62.04±5.12/64.58±5.87	24/16/10/0	空肠造瘘管饲喂养或ONS 4周/常规口服饮食4周	①②④⑧⑨
BOWREY^[17]	2015	20/21	64.6±8.0/63.1±8.7	6/12/22/1	空肠造瘘管饲喂养6周/常规口服饮食6周	①⑧⑨
XIE^[18]	2021	42/35	61.57±8.45/63.06±5.79		ONS 4周/常规口服饮食4周	⑧⑨
CHEN^[19]	2021	53/53	67.83±7.17/67.79±7.24	49/57/0/0	空肠造瘘管饲喂养4周/常规口服饮食4周	②③④⑤⑥⑦⑨⑩
LI^[20]	2020	30/32	63.25±5.23/63.61±5.64	11/23/21/7	空肠造瘘管饲喂养4周/常规口服饮食4周	①②
CHEN^[21]	2021	30/30	70.37±7.58/69.53±9.4	9/27/24/0	ONS 4周/常规口服饮食4周	②③④⑥⑩
ZENG^[22]	2017	30/30	61.7±8.4/59.3±10.4	1/28/31/0	空肠造瘘管饲喂养4周/常规口服饮食4周	⑧⑨⑩
范富翠^[23]	2020	40/40	62.58±6.64/60.88±6.86	Ⅰ~Ⅲ	空肠造瘘管饲喂养4周/常规口服饮食4周	③④⑤⑥⑦⑩
曹子昂^[24]	2013	40/40	65.8/67.4	1/36/42/0	空肠造瘘管饲喂养2个月/常规口服饮食2个月	④⑤⑥⑦⑨
童雅萍^[25]	2018	44/41	62.07±7.06/60.85±8.08	32/53/0/0	空肠造瘘管饲喂养4周/常规口服饮食4周	②③④⑤⑥⑦⑩
刘秀娟^[26]	2021	46/48	59.03±7.79/57.52±7.88	21/51/22/0	十二指肠营养管喂养2个月/常规口服饮食2个月	②③④⑤⑩
王倩^[27]	2019	48/48	53±6.75/55±7.25	41/55/0/0	空肠造瘘管饲喂养4个月/常规口服饮食4个月	①②③④⑤
谷金玲^[28]	2020	41/40	54±8.0/52±7.9	30/42/9/0	空肠造瘘管饲喂养4周/常规口服饮食4周	②③④⑤⑥⑩
石海燕^[29]	2021	34/34	67.3±8.1/68.4±8.5		ONS 4周/常规口服饮食4周	①④⑤⑥

第一作者	发表时间（年）	样本量（E/C）	年龄（E/C）	病理分期（Ⅰ/Ⅱ /Ⅲ/Ⅳ）	干预措施及持续时间（E/C）	结局指标
LIU^[11]	2020	26/24	62.04±5.12/64.58±5.87	24/16/10/0	空肠造瘘管饲喂养或ONS 4周/常规口服饮食4周	①②④⑧⑨
BOWREY^[17]	2015	20/21	64.6±8.0/63.1±8.7	6/12/22/1	空肠造瘘管饲喂养6周/常规口服饮食6周	①⑧⑨
XIE^[18]	2021	42/35	61.57±8.45/63.06±5.79		ONS 4周/常规口服饮食4周	⑧⑨
CHEN^[19]	2021	53/53	67.83±7.17/67.79±7.24	49/57/0/0	空肠造瘘管饲喂养4周/常规口服饮食4周	②③④⑤⑥⑦⑨⑩
LI^[20]	2020	30/32	63.25±5.23/63.61±5.64	11/23/21/7	空肠造瘘管饲喂养4周/常规口服饮食4周	①②
CHEN^[21]	2021	30/30	70.37±7.58/69.53±9.4	9/27/24/0	ONS 4周/常规口服饮食4周	②③④⑥⑩
ZENG^[22]	2017	30/30	61.7±8.4/59.3±10.4	1/28/31/0	空肠造瘘管饲喂养4周/常规口服饮食4周	⑧⑨⑩
范富翠^[23]	2020	40/40	62.58±6.64/60.88±6.86	Ⅰ~Ⅲ	空肠造瘘管饲喂养4周/常规口服饮食4周	③④⑤⑥⑦⑩
曹子昂^[24]	2013	40/40	65.8/67.4	1/36/42/0	空肠造瘘管饲喂养2个月/常规口服饮食2个月	④⑤⑥⑦⑨
童雅萍^[25]	2018	44/41	62.07±7.06/60.85±8.08	32/53/0/0	空肠造瘘管饲喂养4周/常规口服饮食4周	②③④⑤⑥⑦⑩
刘秀娟^[26]	2021	46/48	59.03±7.79/57.52±7.88	21/51/22/0	十二指肠营养管喂养2个月/常规口服饮食2个月	②③④⑤⑩
王倩^[27]	2019	48/48	53±6.75/55±7.25	41/55/0/0	空肠造瘘管饲喂养4个月/常规口服饮食4个月	①②③④⑤
谷金玲^[28]	2020	41/40	54±8.0/52±7.9	30/42/9/0	空肠造瘘管饲喂养4周/常规口服饮食4周	②③④⑤⑥⑩
石海燕^[29]	2021	34/34	67.3±8.1/68.4±8.5		ONS 4周/常规口服饮食4周	①④⑤⑥

家庭肠内营养在食管癌患者中有效性和安全性的Meta分析

The Efficacy and Safety of Home Enteral Nutrition in Patients with Esophageal Cancer: a Meta-analysis

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表 16

参考文献 41

相关文章 15

编辑推荐

Metrics

留言

[1]	程玉, 杨荣, 龙仁, 廖晓阳, 赵洋. 社区基本医疗的随机对照试验研究设计、实施和案例解析[J]. 中国全科医学, 2026, 29(31): 4528-4535.
[2]	魏学娟, 王利华, 王丽, 任静林, 闫海青, 于海洋, 刘景峰. 智能语音外呼辅助传统干预对社区老年"三高"共病患者健康管理的效果研究：一项随机对照试验[J]. 中国全科医学, 2026, 29(31): 4635-4640.
[3]	苏蝶, 张岩, 陈小松, 韩玉霞, 闫永彬, 段俊亚, 陈新颖, 赵成昊. 中医药治疗儿童难治性肺炎支原体肺炎随机对照试验结局指标分析[J]. 中国全科医学, 2026, 29(31): 4609-4618.
[4]	张壹品, 张育康, 谷欣宇, 钱群群, 程露露, 李冬静, 陈朝晖. 理筋正骨手法联合动态神经肌肉稳定技术治疗慢性非特异性腰痛的临床疗效及神经机制初探：一项随机对照研究[J]. 中国全科医学, 2026, 29(30): 4445-4452.
[5]	郭治宏, 陈盈盈, 刘德伍. 抗生素骨水泥联合负压封闭引流技术治疗糖尿病足有效性和安全性的Meta分析[J]. 中国全科医学, 2026, 29(30): 4503-4512.
[6]	胡玉婷, 严颖, 闫明婕, 王惠君, 韩虎. 不同骨改良药物治疗实体瘤骨转移或多发性骨髓瘤患者疗效的网状Meta分析[J]. 中国全科医学, 2026, 29(30): 4489-4502.
[7]	赵聪娟, 金田田, 梁婕, 王贝宁, 高燕. 胰高血糖素样肽1受体激动剂对糖尿病肾脏病患者治疗效果比较：一项网状Meta分析[J]. 中国全科医学, 2026, 29(29): 4326-4336.
[8]	占道伟, 魏绪旺, 胡旻雷, 徐颖梅, 杨喜兵, 罗开涛. 针刺联合替罗非班治疗对溶栓后缺血性脑卒中患者早期神经功能恶化的影响：一项随机对照试验[J]. 中国全科医学, 2026, 29(29): 4241-4247.
[9]	邓玮, 黄梦婷, 易胜利, 林杨, 许力丹, 任哲学, 朱秀琼, 李烨莎, 任梦鸽, 柯大智, 李桂琼, 吴志勤, 骆傲然, 何发培. AI赋能全科临床思维的培养与实施效果研究[J]. 中国全科医学, 2026, 29(28): 4078-4085.
[10]	石力, 周振坤, 刘婕, 潘国凤. 基于经筋理论针罐结合治疗绝经后女性压力性尿失禁的随机对照试验[J]. 中国全科医学, 2026, 29(28): 4141-4146.
[11]	姜妍琳, 王喆, 翟睿, 张梦洁, 陈溪, 王俊宏. 中药复方治疗注意缺陷多动障碍优势方案筛选研究：基于网状Meta分析和熵权TOPSIS法[J]. 中国全科医学, 2026, 29(27): 3985-3994.
[12]	王双瑞, 王勇佳, 范晓敏, 刘湘钰, 胡顺晴, 杨子健, 张新建. 高频与低频星状神经节阻滞联合失眠认知行为疗法治疗失眠障碍的疗效与安全性研究[J]. 中国全科医学, 2026, 29(25): 3678-3685.
[13]	李佳, 何俊, 朱金妹, 刘福明, 吴远, 丁渝权, 钱华, 胥鑫玉. 低容量高强度间歇训练联合虚拟现实技术对冠心病患者心脏康复的干预效果研究[J]. 中国全科医学, 2026, 29(25): 3640-3649.
[14]	焦姝婷, 井浩然, 赵亚利. 北京市城区社区就诊老年患者慢性瘙痒症状强度及影响因素研究[J]. 中国全科医学, 2026, 29(25): 3655-3663.
[15]	刘俞彤, 梅力, 尹平, 李峰, 王茜, 姚望, 陈跃来, 苑成梅. 针刺联合抗焦虑药物治疗广泛性焦虑障碍患者伴发失眠症状的探索性多中心随机对照试验[J]. 中国全科医学, 2026, 29(25): 3670-3677.